Current filters:  
Canada
IP
Patent
Canada
Aird & Berlis LLP
In its recent decision in Nova Chemicals Corporation v. Dow Chemicals Company, 2020 FCA 141, the Federal Court of Appeal clarified the role and calculation of the accounting of profits remedy...
Bereskin & Parr LLP
On October 30, 2019, a number of significant amendments to the Canadian Patent Act and Patent Rules came into force
Norton Rose Fulbright Canada LLP
Des développements récents viennent marquer l'actualité quotidienne en propriété intellectuelle.
Torys LLP
The Federal Court of Canada has rendered a pivotal decision on claims construction in Choueifaty v. Canada (Attorney General) (Choueifaty), which will be welcome news to innovators in the...
Osler, Hoskin & Harcourt LLP
On August 6, 2020, the Federal Court issued its decision in Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC, 2020 FC 816, invalidating Eli Lilly's patent, Canadian Patent No. 2,371,684 ...
Norton Rose Fulbright Canada LLP
Dans une décision très attendue, la Cour suprême du Royaume-Uni a établi que la politique en matière de droits de propriété intellectuelle de l'Institut européen des normes de télécommunication...
Gowling WLG
In an important decision for patent applicants who are concerned about subject matter eligibility.
Dickinson Wright PLLC
The problem-solution approach to claim construction justifies a process of distilling an inventor's words out of his claim with the goal of, in some sense, freeing an essential idea.
Oyen Wiggs Green & Mutala LLP
The Federal Court of Canada recently ruled in Choueifaty v. Canada (Attorney General) that the Canadian Intellectual Property Office's (CIPO's) practice of using a problem-solution approach in...
Aird & Berlis LLP
On August 21, 2020, in Choueifaty v. Canada (Attorney General), 2020 FC 837, the Federal Court held that the Canadian Intellectual Property Office (CIPO) erred in determining the essential..
Smart & Biggar
In a significant decision released August 21, 2020, Choueifaty v Canada (Attorney General), 2020 FC 837 [Choueifaty], Canada's Federal Court rejected the Canadian Intellectual Property Office's...
Borden Ladner Gervais LLP
In a long-awaited decision, the Federal Court of Canada has admonished the Canadian Intellectual Property Office's failure to follow the Supreme Court of Canada (SCC) on claims construction.
McMillan LLP
The Federal Court of Canada's decision in Choueifaty v Attorney General of Canada, 2020 FC 837 ("Choueifaty") will undoubtedly be one of 2020's top patent cases in Canada.
Bereskin & Parr LLP
The Canadian Intellectual Property Office's (CIPO) approach to the question of patentable subject matter – what can be patented – has been much-criticized in recent years as departing from that...
Smart & Biggar
The following provides an overview of the many developments regarding biosimilars in Canada (approvals, pending submissions, regulatory, litigation and market access)...
Dale & Lessmann LLP
As reported earlier, in response to the COVID-19 pandemic, the Canadian Intellectual Property Office (CIPO) has made a series of announcements since its first announcement of March 17, 2020...
Dale & Lessmann LLP
In response to the COVID-19 pandemic and subsequent to its first announcement made on March 17, the Canadian Intellectual Property Office (CIPO)
Norton Rose Fulbright Canada LLP
We advised you that the COVID-19 deadlines were extended to August 24, 2020, and this was the last extension.
Norton Rose Fulbright Canada LLP
Nous vous avons informés du prolongement des délais COVID-19 jusqu'au 24 août 2020, en précisant qu'il s'agissait de la dernière prolongation.
Norton Rose Fulbright Canada LLP
CIPO COVID-19-related extension of deadlines ends August 24, 2020.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media